Submitted Successfully!
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Ver. Summary Created by Modification Content Size Created at Operation
1 -- 1573 2023-07-11 12:16:06 |
2 only format change Meta information modification 1573 2023-07-12 03:00:28 |

Video Upload Options

Do you have a full video?


Are you sure to Delete?
If you have any further questions, please contact Encyclopedia Editorial Office.
Wrede, D.; Bordak, M.; Abraham, Y.; Mehedi, M. Viral Infection-Mediated Pulmonary Epigenetics. Encyclopedia. Available online: (accessed on 30 November 2023).
Wrede D, Bordak M, Abraham Y, Mehedi M. Viral Infection-Mediated Pulmonary Epigenetics. Encyclopedia. Available at: Accessed November 30, 2023.
Wrede, Dylan, Mika Bordak, Yeabtsega Abraham, Masfique Mehedi. "Viral Infection-Mediated Pulmonary Epigenetics" Encyclopedia, (accessed November 30, 2023).
Wrede, D., Bordak, M., Abraham, Y., & Mehedi, M.(2023, July 11). Viral Infection-Mediated Pulmonary Epigenetics. In Encyclopedia.
Wrede, Dylan, et al. "Viral Infection-Mediated Pulmonary Epigenetics." Encyclopedia. Web. 11 July, 2023.
Viral Infection-Mediated Pulmonary Epigenetics

Respiratory viral infections can trigger chronic lung diseases. Number of studies have shown that respiratory viral infection causes epigenetic changes, which refer to genetic alterations that affect gene expression without any mutational genetic changes.

pulmonary pathogen bacteria

1. Introduction

Pulmonary pathogens have been responsible for some of the biggest global health crises in humans for centuries. This is in part due to the efficiency of their mode of transmission. However, their ability to manipulate the human immune system has also been observed as a significant factor. It has already been known that epigenetic alterations play an important role in pathology as well as their ability to modify the immune response [1]. Epigenetic modifications associated with nutrition and the microbiome and their contribution to long-term health development have been well documented [2]. Importantly, the recent research successes show how pulmonary pathogens can modulate the human genome and cause chronic diseases due to the advancement in the OMICS sciences, such as genomics, transcriptomics, proteomics, or metabolomics. For example, genome-wide association studies have revealed genetic changes in different regions of the genome that are primarily associated with complex and nonmalignant respiratory diseases, e.g., chronic obstructive pulmonary disease (COPD), asthma, and pulmonary arterial hypertension (PAH) [3][4][5]. Benincasa et al., have reviewed the epigenetic role in COPD, asthma, and PAH [6]. The epigenetic markers for these common chronic respiratory diseases were identified, e.g., DNA methylation, histone modification, and microRNA (miRNA) [7][8][9][10]. There is growing evidence supporting bacterial infection-induced epigenetic modification in the host by different mechanisms [11]. Viruses are intracellular parasites that continuously utilize the subordination and exploitation of cellular machinery for transcription and translation. Thus, it is no surprise that viruses induce modulation of host chromatin dynamics and transcription regulation, and examples of modulated epigenetic mechanisms are DNA methylation, histone post-translational modification, and transcription modification [12][13]. Bacterial virulence factors can modulate host cell genetic expression rates, limiting the ability of the immune system to adequately respond and allowing replicating bacteria to evade phagocytosis. Multiple virulence factors have been identified in recent studies that may be able to cause lasting pathogenic changes to host cell genomes, some of which may be associated with chronic pathologies such as allergy development, asthma, latent infection, carcinogenesis, and COPD exacerbation. Previously described epigenetic genome modifications, including histone modification, miRNA processing, DNA methylation and acetylation, protein chaperones, and protein degradation processes, all have the potential to upregulate and downregulate host genes at the whim of the invading organism [1][14][15]. These epigenetic changes have potentially chronic or permanent consequences for the host, which can last long after the resolution of the initial infection due to the persistence of some of these changes throughout generations of proliferating cells. Linking the virulence factors of common respiratory infections to consistent host genome modifications and finally to measurable long-term pathogenic outcomes is a potential new front for pulmonary research. The field of infectious epigenetics is still in its early stages, but many authors have already extensively cataloged the most common pathogens and their respective epigenetic targets [1][14][15].

2. Viral Infection-Mediated Pulmonary Epigenetics

Respiratory viral infections can trigger chronic lung diseases [16][17][18]. Asthma is a common chronic disease affecting children in Western countries. Although the pathophysiological changes underlying asthma development are complex and unknown, respiratory syncytial virus (RSV) and human rhinovirus virus (HRV) have been recognized as major etiological factors in wheezing illness, with a significant correlation with asthma development during childhood [19][20]. A recent number of studies have shown that respiratory viral infection causes epigenetic changes, which refer to genetic alterations that affect gene expression without any mutational genetic changes [17]. Here, the research focused on a few common respiratory virus-driven epigenetic changes (Table 1 and Table 2).

2.1. Adenovirus

Adenovirus is a double-stranded DNA virus that commonly causes respiratory infections in humans. It uses a lytic type of life cycle, which is important in its pathophysiology [21]. A common theme in adenovirus infection is the suppression of the expression of most host genes except a few that are involved in cell division [22]. These profound changes are believed to be caused in part by epigenetic changes. ChIP-sip and ChIP-seq-based data analyses suggested that Adenovirus infection was associated with the modulation of two major epigenetic regulations: the organization of certain histone modifications and transcription factors within infected cells. The adenovirus e1a protein appeared to affect the acetylation of H3K9 and H3K18 and certain transcriptional factors [23][24]. Adenovirus protein VII is expressed late in the infected cells and translocates into the nucleus, which allows it to associate with host chromatin; consequently, it alters the chromatin composition of the infected cells. [25][26]. Additionally, the Adenovirus e1A protein is known to localize to host chromatin, alter host histone modifications, and overhaul transcription in infected cells. e1A binds to three different locations on the host’s chromatin. The first site is a region occupied by multiple genes related to the immune response of the host, and e1A binding downregulates these genes [25]. The second site of binding for this protein involves genes involved in the cell cycle. These genes were observed to have been upregulated [21][25]. The genes at the third site of binding are mostly involved in specialization and growth, and these genes were found to have been downregulated. These epigenetic changes hinder the immune system’s ability to respond to an adenovirus infection [25].

2.2. RSV

RSV is a negative-sense, single-stranded RNA virus enveloped by a protein coat. Since RSV affects the epithelial cells of the respiratory tract, the epigenetic factors that may induce changes in these cells are of particular interest. Caixia et al., underlined how the epigenetic dysregulation of signaling pathways in epithelial cells of the respiratory tract is related to shortfalls in immunological functions [27]. This implies that, through the induction of epigenetic modification, the virus can offset the immune response against it. Some of the signaling pathways that RSV can impact are tyrosine kinase growth factor signaling, the hexosamine biosynthetic pathway, and the extracellular matrix secretory pathways [28]. The virus can do this by inducing chromatin remodeling, which involves an increase in the number of nucleosome-free regions. This remodeling affects genes that regulate the aforementioned pathways. The increased accessibility of specific chromatin regions directly affects TGFβ-ECM and HBP pathways, which may explain the airway remodeling that happens in RSV infection [28].
Fonseca et al. [29] discussed that the disparities in immune responses between adults and infants are caused by epigenetic alterations of inflammatory genes. Histone methylation caused by RSV infection has been seen to enhance the production of Th2 cytokines after diminishing the production of pro-inflammatory cytokines. Other observations that have been made in mouse models suggest that RSV is also able to induce changes in non-coding RNAs [29]. These changes were seen to have impacts after the infection had subsided, which involved allergic asthma [29]. By having these effects, the virus is able to increase its own virulence while also having lasting effects, especially on vulnerable hosts.

2.3. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

SARS-CoV-2 is a positive-sense, single-stranded RNA virus that was first identified in the city of Wuhan, China. It is the virus responsible for the respiratory disease coronavirus disease 2019 (COVID-19). The virus has been found to alter the epigenetic environment of the host cell to increase its virulence by disrupting the host’s ability to recognize and respond to the pathogen [30]. Arguably the most significant regulator of the severity of COVID-19 infection is correlated with the increased expression of the receptor ACE2. DNA methylation is one way in which this receptor can be altered by the virus. Decreased DNA methylation close to the transcription site was found to result in increased expression of ACE2 in lung epithelial cells [30]. Chlamydas et al., suggested that the upregulation of the ACE2 receptor on the host cells by the virus is through histone modifications at the DNA packaging histones H3, H3K4me1, H3K4me3, and H3K27Ac [30]. Ozturkler et al., summarized how epigenetic changes such as hypermethylation of IFN genes and hypomethylation of inflammatory genes can be induced by the virus, and this change can be cell-specific [31]. Corley et al., described how, in severe cases of COVID-19, the epigenetic changes in immune cells varied and DNA methylation decreased in primary neutrophils [32].
Table 1. Common viral pulmonary pathogens and their associated epigenetic changes.
Table 2. Main types of epigenetic changes and virus presence in common respiratory viral diseases.
Types of Epigenetic Change Adenovirus SARS-CoV-2 RSV Influenza Virus Rhino Virus MERS
Chromatin remodeling Not Identified Not Identified Yes
Not Identified Not Identified
Changes in DNA methylation Yes
Non-coding RNA   Yes
Changes in DNA acetylation Yes
Not Identified Not Identified Yes
Not Identified Not Identified


  1. Rajeev, R.; Dwivedi, A.P.; Sinha, A.; Agarwaal, V.; Dev, R.R.; Kar, A.; Khosla, S. Epigenetic interaction of microbes with their mammalian hosts. J. Biosci. 2021, 46, 94.
  2. Indrio, F.; Martini, S.; Francavilla, R.; Corvaglia, L.; Cristofori, F.; Mastrolia, S.A.; Neu, J.; Rautava, S.; Russo Spena, G.; Raimondi, F.; et al. Epigenetic Matters: The Link between Early Nutrition, Microbiome, and Long-term Health Development. Front. Pediatr. 2017, 5, 178.
  3. Maselli, D.J.; Bhatt, S.P.; Anzueto, A.; Bowler, R.P.; DeMeo, D.L.; Diaz, A.A.; Dransfield, M.T.; Fawzy, A.; Foreman, M.G.; Hanania, N.A.; et al. Clinical Epidemiology of COPD: Insights From 10 Years of the COPDGene Study. Chest 2019, 156, 228–238.
  4. Rhodes, C.J.; Batai, K.; Bleda, M.; Haimel, M.; Southgate, L.; Germain, M.; Pauciulo, M.W.; Hadinnapola, C.; Aman, J.; Girerd, B.; et al. Genetic determinants of risk in pulmonary arterial hypertension: International genome-wide association studies and meta-analysis. Lancet Respir. Med. 2019, 7, 227–238.
  5. Sakornsakolpat, P.; Prokopenko, D.; Lamontagne, M.; Reeve, N.F.; Guyatt, A.L.; Jackson, V.E.; Shrine, N.; Qiao, D.; Bartz, T.M.; Kim, D.K.; et al. Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations. Nat. Genet. 2019, 51, 494–505.
  6. Benincasa, G.; DeMeo, D.L.; Glass, K.; Silverman, E.K.; Napoli, C. Epigenetics and pulmonary diseases in the horizon of precision medicine: A review. Eur. Respir. J. 2021, 57, 2003406.
  7. Hoang, T.T.; Sikdar, S.; Xu, C.J.; Lee, M.K.; Cardwell, J.; Forno, E.; Imboden, M.; Jeong, A.; Madore, A.M.; Qi, C.; et al. Epigenome-wide association study of DNA methylation and adult asthma in the Agricultural Lung Health Study. Eur. Respir. J. 2020, 56, 2000217.
  8. Napoli, C.; Benincasa, G.; Loscalzo, J. Epigenetic Inheritance Underlying Pulmonary Arterial Hypertension. Arterioscler. Thromb. Vasc. Biol. 2019, 39, 653–664.
  9. Regan, E.A.; Hersh, C.P.; Castaldi, P.J.; DeMeo, D.L.; Silverman, E.K.; Crapo, J.D.; Bowler, R.P. Omics and the Search for Blood Biomarkers in Chronic Obstructive Pulmonary Disease. Insights from COPDGene. Am. J. Respir. Cell Mol. Biol. 2019, 61, 143–149.
  10. DeVries, A.; Vercelli, D. Epigenetic Mechanisms in Asthma. Ann. Am. Thorac. Soc. 2016, 13 (Suppl. S1), S48–S50.
  11. Bierne, H.; Hamon, M.; Cossart, P. Epigenetics and bacterial infections. Cold Spring Harb. Perspect. Med. 2012, 2, a010272.
  12. Youssef, N.; Budd, A.; Bielawski, J.P. Introduction to Genome Biology and Diversity. Methods Mol. Biol. 2019, 1910, 3–31.
  13. Salgado-Albarran, M.; Navarro-Delgado, E.I.; Del Moral-Morales, A.; Alcaraz, N.; Baumbach, J.; Gonzalez-Barrios, R.; Soto-Reyes, E. Comparative transcriptome analysis reveals key epigenetic targets in SARS-CoV-2 infection. NPJ Syst. Biol. Appl. 2021, 7, 21.
  14. Denzer, L.; Schroten, H.; Schwerk, C. From gene to protein—How bacterial virulence factors manipulate host gene expression during infection. Int. J. Mol. Sci. 2020, 21, 3730.
  15. De Monerri, N.C.S.; Kim, K. Pathogens hijack the epigenome: A new twist on host-pathogen interactions. Am. J. Pathol. 2014, 184, 897–911.
  16. Wu, P.; Hartert, T.V. Evidence for a causal relationship between respiratory syncytial virus infection and asthma. Expert Rev. Anti-Infect. Ther. 2011, 9, 731–745.
  17. Pech, M.; Weckmann, M.; Konig, I.R.; Franke, A.; Heinsen, F.A.; Oliver, B.; Ricklefs, I.; Fuchs, O.; Rabe, K.; Hansen, G.; et al. Rhinovirus infections change DNA methylation and mRNA expression in children with asthma. PLoS ONE 2018, 13, e0205275.
  18. Britto, C.J.; Brady, V.; Lee, S.; Dela Cruz, C.S. Respiratory Viral Infections in Chronic Lung Diseases. Clin. Chest Med. 2017, 38, 87–96.
  19. Jackson, D.J.; Gangnon, R.E.; Evans, M.D.; Roberg, K.A.; Anderson, E.L.; Pappas, T.E.; Printz, M.C.; Lee, W.M.; Shult, P.A.; Reisdorf, E.; et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am. J. Respir. Crit. Care Med. 2008, 178, 667–672.
  20. Kusel, M.M.; de Klerk, N.H.; Kebadze, T.; Vohma, V.; Holt, P.G.; Johnston, S.L.; Sly, P.D. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J. Allergy Clin. Immunol. 2007, 119, 1105–1110.
  21. Milavetz, B.I.; Balakrishnan, L. Viral epigenetics. In Cancer Epigenetics; Humana Press: New York, NY, USA, 2015; pp. 569–596.
  22. Tooze, J.; Acheson, N. DNA Tumor Viruses; Cold Spring Harbor Laboratory: Cold Spring Harbor, NY, USA, 1980.
  23. Ferrari, R.; Pellegrini, M.; Horwitz, G.A.; Xie, W.; Berk, A.J.; Kurdistani, S.K. Epigenetic reprogramming by adenovirus e1a. Science 2008, 321, 1086–1088.
  24. Ferrari, R.; Su, T.; Li, B.; Bonora, G.; Oberai, A.; Chan, Y.; Sasidharan, R.; Berk, A.J.; Pellegrini, M.; Kurdistani, S.K. Reorganization of the host epigenome by a viral oncogene. Genome Res. 2012, 22, 1212–1221.
  25. Lynch, K.L.; Gooding, L.R.; Garnett-Benson, C.; Ornelles, D.A.; Avgousti, D.C. Epigenetics and the dynamics of chromatin during adenovirus infections. FEBS Lett. 2019, 593, 3551–3570.
  26. Avgousti, D.C.; Herrmann, C.; Kulej, K.; Pancholi, N.J.; Sekulic, N.; Petrescu, J.; Molden, R.C.; Blumenthal, D.; Paris, A.J.; Reyes, E.D. A core viral protein binds host nucleosomes to sequester immune danger signals. Nature 2016, 535, 173–177.
  27. Caixia, L.; Yang, X.; Yurong, T.; Xiaoqun, Q. Involvement of epigenetic modification in epithelial immune responses during respiratory syncytial virus infection. Microb. Pathog. 2019, 130, 186–189.
  28. Xu, X.; Qiao, D.; Mann, M.; Garofalo, R.P.; Brasier, A.R. Respiratory syncytial virus infection induces chromatin remodeling to activate growth factor and extracellular matrix secretion pathways. Viruses 2020, 12, 804.
  29. Fonseca, W.; Lukacs, N.W.; Ptaschinski, C. Factors affecting the immunity to respiratory syncytial virus: From epigenetics to microbiome. Front. Immunol. 2018, 9, 226.
  30. Chlamydas, S.; Papavassiliou, A.G.; Piperi, C. Epigenetic mechanisms regulating COVID-19 infection. Epigenetics 2021, 16, 263–270.
  31. Ozturkler, Z.; Kalkan, R. A New Perspective of COVID-19 Infection: An Epigenetics Point of View. Glob. Med. Genet. 2022, 9, 004–006.
  32. Corley, M.J.; Pang, A.P.; Dody, K.; Mudd, P.A.; Patterson, B.K.; Seethamraju, H.; Bram, Y.; Peluso, M.J.; Torres, L.; Iyer, N.S. Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19. J. Leukoc. Biol. 2021, 110, 21–26.
  33. Khan, M.A.-A.-K.; Sany, M.R.U.; Islam, M.S.; Islam, A.B.M.M.K. Epigenetic regulator miRNA pattern differences among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 world-wide isolates delineated the mystery behind the epic pathogenicity and distinct clinical characteristics of pandemic COVID-19. Front. Genet. 2020, 11, 765.
  34. Marcos-Villar, L.; Diaz-Colunga, J.; Sandoval, J.; Zamarreno, N.; Landeras-Bueno, S.; Esteller, M.; Falcon, A.; Nieto, A. Epigenetic control of influenza virus: Role of H3K79 methylation in interferon-induced antiviral response. Sci. Rep. 2018, 8, 1230.
  35. Mukherjee, S.; Vipat, V.C.; Chakrabarti, A.K. Infection with influenza A viruses causes changes in promoter DNA methylation of inflammatory genes. Influenza Other Respir. Viruses 2013, 7, 979–986.
  36. Menachery, V.D.; Schafer, A.; Burnum-Johnson, K.E.; Mitchell, H.D.; Eisfeld, A.J.; Walters, K.B.; Nicora, C.D.; Purvine, S.O.; Casey, C.P.; Monroe, M.E.; et al. MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape. Proc. Natl. Acad. Sci. USA 2018, 115, E1012–E1021.
Subjects: Virology
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to : , , ,
View Times: 82
Revisions: 2 times (View History)
Update Date: 12 Jul 2023